VIP-targeted cytotoxic nanomedicine for breast cancer

ISSN： 2190-393X

Source： Drug Delivery and Translational Research, Vol.2, Iss.6, 2012-12, pp. : 454-462

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost Effectiveness of Cytotoxic and Targeted Therapy for Metastatic Breast Cancer: A Critical and Systematic Review

By Blank Patricia R.

PharmacoEconomics, Vol. 28, Iss. 8, 2010-08 ,pp. : 629-647

Adis International

Access to resources Recommend Favorite

Targeted Therapy of Breast Cancer

Current Pharmaceutical Design, Vol. 13, Iss. 5, 2007-02 ,pp. : 497-517

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted therapy combos promising for breast cancer

Inpharma, Vol. 1, Iss. 1640, 2008-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Emergence of Nanomedicine as Cancer Targeted Magic Bullets: Recent Development and Need to Address the Toxicity Apprehension

Current Drug Discovery Technologies, Vol. 9, Iss. 4, 2012-12 ,pp. : 319-329

Bentham Science Publishers

Access to resources Recommend Favorite

Chemokines and Breast Cancer: A Gateway to Revolutionary Targeted Cancer Treatments?

Current Medicinal Chemistry, Vol. 10, Iss. 7, 2003-04 ,pp. : 579-592

Bentham Science Publishers

Access to resources Recommend Favorite